logo
Plus   Neg
Share
Email

AstraZeneca Covid Vaccine Trials Halted On Children And Teenagers By Oxford

The University of Oxford reported on Tuesday that it is halting the trial of the COVID vaccine developed by AstraZeneca PLC (AZN) on children and teenagers. The vaccine, developed in collaboration with AstraZeneca and Oxford, is under scrutiny for resulting in blood clots in the recipients.

The pediatric trial started in mid-February with 200 youths in the age range of 6-17 in mind, will await the reports of the Medicines and Healthcare products Regulatory Agency before resumption. However, Oxford has not revealed the number of children administered with the shot as of now.

This latest news rams another blow at the AstraZeneca vaccine which has been circulated in more than 70 countries till now. The company was also planning to gain permission to use the vaccine in the US from July.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Uber Technologies Inc. (UBER) Wednesday reported a first-quarter loss that narrowed from last year, despite revenues dropping 16%, reflecting a gain from sale of self-driving unit. The ride-hail service's fourth-quarter loss was narrower than Wall Street estimates, but revenues fell short of expectations.... Social media giant Facebook's Workplace business tool has breached the seven million paid subscribers mark at a time when jobs have gone remote and is now the new normal amid the ongoing pandemic. The number of paid subscribers has grown 40 percent from last year. General Motors Co. (GM) Wednesday reported a profit for the first-quarter that surged from last year, driven by strong price and mix performance in North America, strong credit and residual value performance at GM Financial, as well as the industry recovery in China. Earnings per share topped analysts' expectations, while quarterly revenues missed their estimates.
Follow RTT